Key result
Higher urinary albumin-to-creatinine ratio within the normoalbuminuric range independently predicted a higher 6-year risk of major adverse cardiovascular events (adjusted HR 1.67) in adults with T2DM.
Why the study?
The prognostic significance of urinary albumin excretion within the normoalbuminuric range remains uncertain in type 2 diabetes mellitus, particularly regarding sex-specific differences.
Does higher urinary albumin-to-creatinine ratio within the normoalbuminuric range predict major adverse cardiovascular events and coronary artery disease severity in adults with type 2 diabetes and preserved kidney function?
Cohort (n=420)
No
Does higher urinary albumin-to-creatinine ratio within the normoalbuminuric range predict major adverse cardiovascular events and coronary artery disease severity in adults with type 2 diabetes and preserved kidney function?
Effect estimate: HR 1.67 (95% CI 1.35-2.10)
p-value: p=<0.01
In adults with type 2 diabetes and preserved kidney function, higher urinary albumin-to-creatinine ratio even within the normal range (<30 mg/g) independently predicts greater coronary artery disease severity and 6-year MACE risk.
BACKGROUND: Urinary albumin excretion is an established marker of cardiovascular (CV) risk in people with type 2 diabetes mellitus (T2DM). However, its prognostic significance within the normoalbuminuric range (< 30 mg/g) remains uncertain, particularly regarding sex-specific differences. This study examined whether urinary albumin-to-creatinine ratio (UACR; KDIGO A1 range) is associated with coronary artery disease (CAD) severity and 6-year major adverse cardiovascular events (MACE) in women and in men with T2DM and preserved kidney function (eGFR > 60 mL/min/1.73 m², UACR < 30 mg/g), treating sex differences as a co-primary objective. METHODS: We conducted a retrospective cohort study involving adults with T2DM who underwent diagnostic coronary angiography. Baseline associations between log-transformed UACR, CAD severity, CV risk factors, and inflammatory markers were evaluated using multivariable linear regression. MACE (defined as non-fatal myocardial infarction or unstable angina requiring urgent revascularization, stroke, or CV death) were recorded during 6-year of follow-up. Cox proportional hazards models, adjusted for age, sex, hypertension, smoking, BMI, lipid profile, hs-CRP, and ACEI/ARB use, were used to assess UACR-MACE associations. RESULTS: We included 420 adults (180 women, 42.9%) with a mean of age 65.3 ± 10.7 years and a median UACR 7.56 mg/g (IQR 4.12-15.5). Significant CAD was present in 310 participants (73.8%), and 78 experienced MACE during follow-up (35.5%). Higher UACR was independently associated with greater coronary stenosis (adjusted R² = 0.090, p < 0.001). Kaplan-Meier analysis showed a significantly higher incidence of MACE in the highest UACR tertile (log-rank p = 0.039). In multivariable Cox models adjusted for age, sex, hypertension, smoking, lipid profile, hs-CRP, SSI, and ACEI/ARB use, higher log-UACR independently predicted MACE (adjusted HR 1.67, 95% CI 1.35-2.10; p < 0.01). In sex-stratified Cox models, higher log-UACR predicted MACE in both sexes and remained independently associated in multivariable analyses (adjusted HR 1.67, 95% CI 1.35-2.10; p < 0.01). Associations were directionally stronger in women, who showed higher cumulative event rates across UACR tertiles, although the formal UACR × sex interaction did not reach statistical significance. CONCLUSIONS: Within the normoalbuminuric range, UACR is associated with greater CAD burden and higher 6-year MACE risk, with sex-specific differences. These findings suggest potential sex-related variation in the prognostic value of high-normal albuminuria, particularly among women, warranting validation in larger and more diverse cohorts.
No takes yet. Share an insight, caveat, or question.
Siverio-Morales et al. (2025) conducted a cohort in Type 2 diabetes mellitus with preserved kidney function and normoalbuminuria (n=420). Higher urinary albumin-to-creatinine ratio (log-UACR) vs. Lower urinary albumin-to-creatinine ratio was evaluated on Major adverse cardiovascular events (MACE) (HR 1.67, 95% CI 1.35-2.10, p=<0.01). Higher urinary albumin-to-creatinine ratio within the normoalbuminuric range independently predicted a higher 6-year risk of major adverse cardiovascular events (adjusted HR 1.67) in adults with T2DM.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: